PER 1.41% 7.0¢ percheron therapeutics limited

People are talking Sarepta and Pfizer but it would appear our...

  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    People are talking Sarepta and Pfizer but it would appear our active support and interest and our initial projected route to market will be through the EU

    So maybe we should be looking at one of these to take an interest

    https://europe.businesschief.com/top10/1543/Top-10-pharmaceutical-companies-in-Europe

    The Company is encouraged by the initial feedback it received from discussions with internationally recognized DMD experts, who are actively involved in developing new therapies for DMD in Europe and with whom the Company is consulting in regard to the ongoing development of ATL1102 and the Phase IIb clinical trial

    You just never never know
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.